Cargando…
Adaptive Immunity and the Risk of Autoreactivity in COVID-19
While first and foremost considered a respiratory infection, COVID-19 can result in complications affecting multiple organs. Immune responses in COVID-19 can both protect against the disease as well as drive it. Insights into these responses, and specifically the targets being recognised by the immu...
Autores principales: | Moody, Rhiane, Wilson, Kirsty, Flanagan, Katie L., Jaworowski, Anthony, Plebanski, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396528/ https://www.ncbi.nlm.nih.gov/pubmed/34445670 http://dx.doi.org/10.3390/ijms22168965 |
Ejemplares similares
-
Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells
por: Moody, Rhiane, et al.
Publicado: (2020) -
Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity
por: Moody, Rhiane, et al.
Publicado: (2021) -
Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy
por: Moody, Rhiane, et al.
Publicado: (2021) -
Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes
por: Moody, Rhiane, et al.
Publicado: (2022) -
Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression
por: Cox, Momodou, et al.
Publicado: (2021)